This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: The Innovative Mind of Mary Jo Zaborowski: Pioneering Alpha1a Adrenergic Receptor Antagonists
Introduction: Mary Jo Zaborowski, a trailblazing inventor based in Westfield, NJ, has made a significant impact in the field of pharmaceuticals with her groundbreaking patent for Alpha1a adrenergic receptor antagonists.
Latest Patents: Zaborowski's notable patent involves compounds that specifically bind to the human alpha1a adrenergic receptor, demonstrating effectiveness in reducing symptoms of benign prostatic hypertrophy. The compounds are defined by a unique formula aimed at addressing this prevalent health condition.
Career Highlights: Zaborowski's professional journey is intertwined with Merck & Company, Inc., a renowned pharmaceutical giant. Her dedication to research and innovation has led to the development of cutting-edge solutions in the medical realm.
Collaborations: Throughout her career, Zaborowski has collaborated with esteemed colleagues such as Linda S. Payne and Steven D. Young. Together, they have worked synergistically to advance scientific knowledge and foster innovation in the pharmaceutical industry.
Conclusion: Mary Jo Zaborowski's ingenuity and commitment to scientific advancement exemplify the spirit of innovation. Her contributions to the field of pharmaceuticals, particularly in the realm of Alpha1a adrenergic receptor antagonists, continue to propel the industry forward, offering hope and improved solutions for individuals worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile